Global NK Cells Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of NK Cells

• 1.1 Definition of NK Cells
• 1.2 NK Cells Segment by Type
  • 1.2.1 Global NK Cells Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Mogamulizumab
  • 1.2.3 Lorvotuzumab Mertansine
  • 1.2.4 Others
• 1.3 NK Cells Segment by Applications
  • 1.3.1 Global NK Cells Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Cancer
  • 1.3.3 Cardiovascular Diseases
  • 1.3.4 Others
• 1.4 Global NK Cells Overall Market
  • 1.4.1 Global NK Cells Revenue (2014-2025)
  • 1.4.2 Global NK Cells Production (2014-2025)
  • 1.4.3 North America NK Cells Status and Prospect (2014-2025)
  • 1.4.4 Europe NK Cells Status and Prospect (2014-2025)
  • 1.4.5 China NK Cells Status and Prospect (2014-2025)
  • 1.4.6 Japan NK Cells Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia NK Cells Status and Prospect (2014-2025)
  • 1.4.8 India NK Cells Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of NK Cells
• 2.3 Manufacturing Process Analysis of NK Cells
• 2.4 Industry Chain Structure of NK Cells

3 Development and Manufacturing Plants Analysis of NK Cells

• 3.1 Capacity and Commercial Production Date
• 3.2 Global NK Cells Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of NK Cells
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 NK Cells Production and Capacity Analysis
• 4.2 NK Cells Revenue Analysis
• 4.3 NK Cells Price Analysis
• 4.4 Market Concentration Degree

5 NK Cells Regional Market Analysis

• 5.1 NK Cells Production by Regions
  • 5.1.1 Global NK Cells Production by Regions
  • 5.1.2 Global NK Cells Revenue by Regions
• 5.2 NK Cells Consumption by Regions
• 5.3 North America NK Cells Market Analysis
  • 5.3.1 North America NK Cells Production
  • 5.3.2 North America NK Cells Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America NK Cells Import and Export
• 5.4 Europe NK Cells Market Analysis
  • 5.4.1 Europe NK Cells Production
  • 5.4.2 Europe NK Cells Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe NK Cells Import and Export
• 5.5 China NK Cells Market Analysis
  • 5.5.1 China NK Cells Production
  • 5.5.2 China NK Cells Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China NK Cells Import and Export
• 5.6 Japan NK Cells Market Analysis
  • 5.6.1 Japan NK Cells Production
  • 5.6.2 Japan NK Cells Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan NK Cells Import and Export
• 5.7 Southeast Asia NK Cells Market Analysis
  • 5.7.1 Southeast Asia NK Cells Production
  • 5.7.2 Southeast Asia NK Cells Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia NK Cells Import and Export
• 5.8 India NK Cells Market Analysis
  • 5.8.1 India NK Cells Production
  • 5.8.2 India NK Cells Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India NK Cells Import and Export

6 NK Cells Segment Market Analysis (by Type)

• 6.1 Global NK Cells Production by Type
• 6.2 Global NK Cells Revenue by Type
• 6.3 NK Cells Price by Type

7 NK Cells Segment Market Analysis (by Application)

• 7.1 Global NK Cells Consumption by Application
• 7.2 Global NK Cells Consumption Market Share by Application (2014-2019)

8 NK Cells Major Manufacturers Analysis

• 8.1 Chipscreen Biosciences (China)
  • 8.1.1 Chipscreen Biosciences (China) NK Cells Production Sites and Area Served
  • 8.1.2 Chipscreen Biosciences (China) Product Introduction, Application and Specification
  • 8.1.3 Chipscreen Biosciences (China) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Affimed NV (Netherlands)
  • 8.2.1 Affimed NV (Netherlands) NK Cells Production Sites and Area Served
  • 8.2.2 Affimed NV (Netherlands) Product Introduction, Application and Specification
  • 8.2.3 Affimed NV (Netherlands) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Altor BioScience Corporation (USA)
  • 8.3.1 Altor BioScience Corporation (USA) NK Cells Production Sites and Area Served
  • 8.3.2 Altor BioScience Corporation (USA) Product Introduction, Application and Specification
  • 8.3.3 Altor BioScience Corporation (USA) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Innate Pharma SA (France)
  • 8.4.1 Innate Pharma SA (France) NK Cells Production Sites and Area Served
  • 8.4.2 Innate Pharma SA (France) Product Introduction, Application and Specification
  • 8.4.3 Innate Pharma SA (France) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Takeda Pharmaceutical (Japan)
  • 8.5.1 Takeda Pharmaceutical (Japan) NK Cells Production Sites and Area Served
  • 8.5.2 Takeda Pharmaceutical (Japan) Product Introduction, Application and Specification
  • 8.5.3 Takeda Pharmaceutical (Japan) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sorrento Therapeutics Inc. (USA)
  • 8.6.1 Sorrento Therapeutics Inc. (USA) NK Cells Production Sites and Area Served
  • 8.6.2 Sorrento Therapeutics Inc. (USA) Product Introduction, Application and Specification
  • 8.6.3 Sorrento Therapeutics Inc. (USA) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 NantKwest Inc. (USA)
  • 8.7.1 NantKwest Inc. (USA) NK Cells Production Sites and Area Served
  • 8.7.2 NantKwest Inc. (USA) Product Introduction, Application and Specification
  • 8.7.3 NantKwest Inc. (USA) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Bristol-Myers Squibb (USA)
  • 8.8.1 Bristol-Myers Squibb (USA) NK Cells Production Sites and Area Served
  • 8.8.2 Bristol-Myers Squibb (USA) Product Introduction, Application and Specification
  • 8.8.3 Bristol-Myers Squibb (USA) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 NKT Therapeutics (USA)
  • 8.9.1 NKT Therapeutics (USA) NK Cells Production Sites and Area Served
  • 8.9.2 NKT Therapeutics (USA) Product Introduction, Application and Specification
  • 8.9.3 NKT Therapeutics (USA) NK Cells Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of NK Cells Market

• 9.1 Global NK Cells Market Trend Analysis
  • 9.1.1 Global NK Cells Market Size (Volume and Value) Forecast 2019-2025
• 9.2 NK Cells Regional Market Trend
  • 9.2.1 North America NK Cells Forecast 2019-2025
  • 9.2.2 Europe NK Cells Forecast 2019-2025
  • 9.2.3 China NK Cells Forecast 2019-2025
  • 9.2.4 Japan NK Cells Forecast 2019-2025
  • 9.2.5 Southeast Asia NK Cells Forecast 2019-2025
  • 9.2.6 India NK Cells Forecast 2019-2025
• 9.3 NK Cells Market Trend (Product Type)
• 9.4 NK Cells Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 NK Cells Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List